1. Home
  2. USEG vs VERU Comparison

USEG vs VERU Comparison

Compare USEG & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Energy Corp. (DE)

USEG

U.S. Energy Corp. (DE)

HOLD

Current Price

$1.15

Market Cap

40.5M

Sector

Energy

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.65

Market Cap

41.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USEG
VERU
Founded
1966
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.5M
41.7M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
USEG
VERU
Price
$1.15
$2.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$3.50
$22.50
AVG Volume (30 Days)
4.9M
65.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
25.00
N/A
EPS
N/A
N/A
Revenue
$32,379,000.00
$16,296,958.00
Revenue This Year
N/A
N/A
Revenue Next Year
$57.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$0.36
52 Week High
$2.75
$4.59

Technical Indicators

Market Signals
Indicator
USEG
VERU
Relative Strength Index (RSI) 54.26 57.83
Support Level $1.12 $2.15
Resistance Level $1.29 $2.77
Average True Range (ATR) 0.11 0.16
MACD 0.02 0.02
Stochastic Oscillator 34.21 91.67

Price Performance

Historical Comparison
USEG
VERU

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: